11/20/2024
7:01 AM | PMV Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/14/2024
11:24 AM | ArrowMark Colorado Holdings LLC (Filed by)
PMV Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/07/2024
7:00 AM | PMV Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
7:00 AM | PMV Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/12/2024
4:59 PM | Carulli Michael (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
5:00 PM | Jalota Deepika (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
7:00 AM | PMV Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
08/08/2024
7:00 AM | PMV Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/16/2024
8:02 AM | PMV Pharmaceuticals (Subject)
| Form SC TO-I | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
PMV Pharmaceuticals (Subject)
| Form SC 13G/A | |
06/10/2024
3:43 PM | LEVINE ARNOLD J (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:44 PM | PMV Pharmaceuticals (Issuer)
Stelzer Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:17 PM | FLOWERS KIRSTEN (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:21 PM | Gallagher Carol Giltner (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:22 PM | Heyman Richard A. (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:32 AM | PMV Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
7:00 AM | PMV Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
7:00 AM | PMV Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
7:00 AM | PMV Pharmaceuticals (Filer)
| Form DEF 14A | |
04/24/2024
7:01 AM | PMV Pharmaceuticals (Filer)
| Form DEFA14A | |
04/24/2024
7:02 AM | PMV Pharmaceuticals (Filer)
| Form ARS | |
04/09/2024
12:17 PM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
PMV Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/29/2024
3:05 PM | PMV Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
3:05 PM | PMV Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
2:38 PM | ArrowMark Colorado Holdings LLC (Filed by)
PMV Pharmaceuticals (Subject)
| Form SC 13G | |
02/14/2024
8:18 AM | Avoro Capital Advisors LLC (Filed by)
PMV Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
6:52 AM | PMV Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
01/29/2024
2:26 PM | PMV Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/24/2024
8:01 AM | PMV Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/23/2024
8:07 AM | PMV Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/23/2024
8:40 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
PMV Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/22/2024
3:02 PM | Mack David Henry (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
3:04 PM | Carulli Michael (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
3:06 PM | Jalota Deepika (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
3:18 PM | Carulli Michael (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/24/2023
3:38 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP V LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
